Interactions between morphine, scopolamine and nicotine: Schedule-controlled responding in rats

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 1, 2010, Pages 91-95

  Li, Xinwang ^a   Li, Jun Xu ^b   France, Charles P ^b  

^a CAPITAL NORMAL UNIVERSITY   (China)

^b University of Texas Health Science Center   (United States)

Author keywords

Acetylcholine; Interaction; Isobologram; Morphine; Nicotine; Opioid; Rat; Scopolamine

Indexed keywords

CHOLINERGIC RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NICOTINE TARTRATE; NICOTINIC RECEPTOR; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; FEEDING BEHAVIOR; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REACTION TIME; STIMULUS RESPONSE; TASK PERFORMANCE; TIME;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG SYNERGISM; MALE; MORPHINE; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; REINFORCEMENT SCHEDULE; SCOPOLAMINE;

RATTUS;

EID: 77953292179     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.04.011     Document Type: Article

References (26)

1. Buccafusco J.J., Bain J.N. A 24-h access I.V. self-administration schedule of morphine reinforcement and the estimation of recidivism: pharmacological modification by arecoline. Neuroscience 2007, 149:487-498.
2. Carter L.P., Flores L.R., Wu H., Chen W., Unzeitig A.W., Coop A. The role of GABAB receptors in the discriminative stimulus effects of gamma-hydroxybutyrate in rats: time course and antagonism studies. J Pharmacol Exp Ther 2003, 305:668-674.
3. De Marinis L., Mancini A., Valle D., Fiumara C., Conte G., Bianchi A., Perrelli M., Gentilella R., Giustina A. Physiological role of the opioid-cholinergic interaction in growth hormone neuroregulation: effect of sex and food intake. Metabolism 1997, 740-744.
4. Fišerová M., Consolo S., Kršiak M. Chronic morphine induces long-lasting changes in acetylcholine release in rat nucleus accumbens core and shell: an in vivo microdialysis study. Psychopharmacology 1999, 142:85-94.
5. Gessner P.K. A straightforward method for the study of drug interactions: an isobolographic analysis primer. J Am Coll Toxicol 1988, 7:987-1012.
6. Glick S.D., Maisonneuve I.M., Kitchen B.A. Modulation of nicotine self-administration in rats by combination therapy with agents blocking α3β4 nicotinic receptors. Eur J Pharmacol 2002, 448:185-191.
7. Haghparast A., Khani A., Naderi N., Alizadeh A.M., Motamedi F. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice. Pharmacol Biochem Behav 2008, 88:385-392.
8. Introini I.B., Baratti C.B. The impairment of retention induced by β-endorphin in mice may be mediated by reduction of central cholinergic activity. Behav Neural Biol 1984, 41:152-163.
9. Ishizaki J., Yokogawa K., Nakashima E., Takayasu T., Ohshima T., Ichimura F. Effect of sequence of administration on the pharmacokinetic interaction between the anticholinergic drug biperiden and [3H]quinuclidinyl benzylate or [3H]N-methylscopolamine in rats. J Pharm Pharmacol 1998, 50:189-196.
10. Lelas S., Rowlett J.K., Spealman R.D. Isobolographic analysis of chlordiazepoxide and triazolam combinations in squirrel monkeys discriminating triazolam. Psychopharmacology 2001, 158:181-189.
11. Li Z., Wu C.F., Pei G., Xu N.J. Reversal of morphine-induced memory impairment in mice by withdrawal in Morris water maze possible involvement of cholinergic system. Pharmacol Biochem Behav 2001, 68:507-513.
12. Li X., Xu A., Yu B., Wang J., Guo C. Effects of scopolamine on behavioral sensitization induced by morphine in rats. Acta Psychol Sin 2007, 39:299-305.
13. 9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception. Psychopharmacology 2008, 199:199-208.
14. Lu L., Nan-Jie Xu X.G., Yue W. Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization. Psychopharmacology 2002, 159:125-132.
15. Oka T., Hosoya E. Effects of humoral modulators and naloxone on morphine-induced changes in the spontaneous locomotor activity of the rat. Psychopharmacology 1976, 47:243-248.
16. Osman N.I., Baghdoyan H.A., Lydic R. Morphine inhibits acetylcholine release in rat prefrontal cortex when delivered systemically or by microdialysis to basal forebrain. Anesthesiology 2005, 103:779-787.
17. Rada P.V., Mark G.P., Taylor K.M., et al. Morphine and naloxone, i.p or locally, affect extracellular acetylcholine in the accumbens and prefrontal cortex. Pharmacol Biochem Behav 1996, 53:809-816.
18. Ragozzino M.E., Wenk G.L., Gold P.E. Glucose attenuates a morphine-induced decrease in hippocampal acetylcholine output: an in vivo microdialysis study in rats. Brain Res 1994, 655:77-82.
19. Shams J., Sahraei H., Gholami A., Haeri-Rohani A., Alaf-Javadi M., Sepehri H., Salimi S.H., Ghoshooni H. Effects of ultra-low doses of nicotine on the expression of morphine-induced conditioned place preference in mice. Behav Pharmacol 2006, 17:629-635.
20. Tan H., Liu N., Wilson F.A., Ma Y. Effects of scopolamine on morphine-induced conditioned place preference in mice. Addict Biol 2007, 12:463-469.
21. Tjon G.H., De Vries T.J., Nestby P., Wardeh G., Mulder A.H., Schoffelmeer A.N. Intermittent and chronic morphine treatment induces long-lasting changes in delta-opioid receptor-regulated acetylcholine release in rat striatum and nucleus accumbens. Eur J Pharmacol 1995, 283:169-176.
22. Zarrindast M.R., Faraji N., Rostami P., Sahraei H., Ghoshouni H. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice. Pharmacol Biochem Behav 2003, 74:363-369.
23. Zarrindast M.R., Nouraei N., Khallilzadeh A., Askari E. Influence of acute and sub-chronic nicotine pretreatment on morphine state-dependent learning. Behav Brain Res 2006, 173:268-273.
24. Zhai H., Wu P., Chen S., Li F., Liu Y., Lu L. Effects of scopolamine and ketamine on reconsolidation of morphine conditioned place preference in rats. Behav Pharmacol 2008, 19:211-216.
25. Zhang W., Yamada M., Gomeza J., Basile A.S., Wess J. Multiple muscarinic acetylcholine receptor subtypes modulate striatal dopamine release, as studied with M1-M5 muscarinic receptor knock-out mice. J Neurosci 2002, 22:6347-6352.
26. Zhou H., Ge X., Wang L.Z., Ma L., Pei G. Attenuation of morphine tolerance and dependence in scopolamine-treated rats. Neuroreport 1999, 10:2007-2010.